Jane Henderson, Director: Akero Therapeutics AKRO Sell · Filed 23/06/21

Trade details

Type: Insider sale
Amount: $1,225,241.08
Shares · price: 22,498 sh · $54.46 a share
Held after: 0 sh
Stock: Akero Therapeutics AKRO
Person: Jane HendersonDirector
Trade date: 23/06/16
Filed: 23/06/21
Days to filing: 5 days

Sold 100.0% of holdings

Share of holding sold: 100.0%

Akero Therapeutics trades, last 26 weeks

What else happened in Akero Therapeutics around then

Filed or reported within 30 days of the trade day · 23/05/17~23/07/16

Jane Henderson's recent trades

Jane HendersonCFO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$74.3K
900 sh
$74.3K
Filed 05/04
Traded 05/01
Jane HendersonCFO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$65.7K
811 sh
$65.7K
Filed 05/04
Traded 05/01
Jane HendersonCFO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$24K
289 sh
$24K
Filed 05/04
Traded 05/01
Jane HendersonCFO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$180K
2,000 sh
$180K
Filed 04/17
Traded 04/16
Jane HendersonCFO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$94K
1,100 sh
$94K
Filed 04/03
Traded 04/01

Jane Henderson, Director — sold $1.2M of Akero Therapeutics AKRO · 100.0% of holdings | Whalegun